Junwei Wang
Guangzhou Medical University
9 Papers
Junwei Wang is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Purinergic Receptor P2 × 7 Contributes to Abdominal Aortic Aneurysm Development via Modulating Macrophage Pyroptosis and Inflammation.
Likun Sun,Xin Li,Zhongchen Luo,Maohua Li,Hongyu Liu,Zhaowei Zhu,Junwei Wang,Peng Lu,Lunchang Wang,Chenzi Yang,Tun Wang,Hao He,Ming Li,Chang Shu,Jiehua Li +14 more
TL;DR: In this paper , the purinergic receptor P2X7 plays essential roles in abdominal aortic aneurysms (AAA) development via modulating macrophage pyroptosis and inflammation.
17
Comparative Efficacy and Safety of Endovascular Treatment Modalities for Femoropopliteal Artery Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Yang Zhou,Zhihui Zhang,Shaomang Lin,Jian-bin Xiao,Wenjia Ai,Junwei Wang,Yangyong Li,Qiang Li +7 more
TL;DR: A network meta-analysis of randomized controlled trials comparing the efficacy and safety of multiple endovascular treatments for femoropopliteal lesions found that DA may be better than other treatments in terms of major amputation and all-cause mortality, while NS seems to be less safe.
6
Safety and efficacy of thoracic endovascular aortic repair for acute Stanford type B aortic dissection with retrograde type A intramural hematoma.
Junwei Wang,Ming Li,Jiehua Li,Hao He,Yang Zhou,Xin Li,Quanming Li,Feng Gu,Zijian Ye,Alan Dardik,Chang Shu +10 more
TL;DR: In this article , the authors evaluated safety and efficacy of thoracic endovascular aortic repair (TEVAR) for acute Stanford type B dissection (TBAD) with retrograde type A intramural hematoma (TAIMH).
4
Comparative Effectiveness of Treatment Modalities for Complex Aortic Aneurysms: A Network Meta-Analysis of Observational Studies.
TL;DR: In this article , the authors conducted a network meta-analysis comparing multiple treatments for complex aortic aneurysms (CAAs) and found that open surgery was the most effective treatment and had higher 24-month branch vessel patency rates than CEVAR and FEVAR.
1
1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections
Chang Shu,Hao He,Weiguo Fu,Wei Guo,Ming Li,Erping Xi,Shuguang Guo,Xueming Chen,Zhanxiang Xiao,Zhiqiang Yu,Jianhua Huang,Xiangchen Dai,Zhiwei Wang,Wei Li,Qi Zheng,Quanming Li,Lunchang Wang,Xin Li,Junwei Wang,Feng Gu +19 more
TL;DR: The one-year outcomes from this prospective, randomized, multicenter study demonstrate that Ankura II stent graft shows comparable results to Ankura for treating TBADs, resulting in low mortality rates, MAEs and reintervention rates.